Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development
General Info
Coverage type
Country
Time period covered
January, 2009 - December, 2012
Data type
Scientific literature
Citation
Journal
HIV Clin Trials
Pages
1-10
Publication year
2012
Suggested citation
Morris BL, Scott CA, Wilkin TJ, Sax PE, Gulick RM, Freedberg KA, Schackman BR. Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development. HIV Clin Trials. 2012; 13(1): 1-10.